Search Results 281-290 of 23995 for prostate cancer
... Prostate Cancer. Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer ...
Safety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) ...
Learn about this prostate cancer screening test, including why it's done, what to expect, risks and results.
Treating prostate cancer with prostate brachytherapy. Get the facts about this form of radiation that helps treat prostate cancer. Learn about possible risks ...
The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene ...
While it's not the same as prostate cancer, an enlarged prostate can cause significant quality of life issues. Dr. Scott Cheney, a Mayo Clinic urologist ...
In men, radical cystectomy typically includes removal of the prostate and seminal vesicles. In women, radical cystectomy may involve removal of the uterus ...
Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer. Print details. Share; Facebook · Twitter. Overview; Participation eligibility ...
Prostate cancer is treatable and potentially curable when detected early. ... prostate cancers and the surveillance of less aggressive prostate cancers.
prostate cancer are expected to be diagnosed this year. "The reality is that prostate cancer is the most commonly diagnosed solid malignancy in men," says ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.